MM+M 2020 Career & Salary Survey Premium Edition
Is healthcare marketing really a recession-proof profession? If this year’s compensation trends are any indication, the answer is mixed.
Print Issue: October 01, 2020
Digital Edition: 2020 Career and Salary Survey Issue
This issue includes the 2020 Career and Salary Survey, a feature on nurse practitioners and physician’s assistants, agencies transitioning to virtual work and more.
Marketers on COVID, Black Lives Matter and immersive tech
Marketers from Fishawack Health and HealthPrize Technologies discuss behavioral marketing and immersive technology.
Six degrees of medical marketing separation: Web of connections among four marketers
Do we have our first direct connection between an MM+M-world luminary and Kevin Bacon himself? Indeed we do.
2020 Career and Salary Survey: Is COVID responsible for the 12% drop in average salary?
Respondents to the annual MM+M/AbelsonTaylor Career and Salary Survey report a 12% drop in average salary in 2020. Whether that’s attributable to COVID-19 or a sign of darker days to come is anybody’s guess.
AbelsonTaylor’s Jay Carter unpacks the Career and Salary Survey results
Jay Carter is EVP and director of business development at AbelsonTaylor.
Virtual office: Agencies on the mechanics of a major shift
Agencies have been quick to declare their seamless transition to virtual work, but what do the mechanics of the major shift really entail? We highlight some of the most useful solutions.
HCPs finally embrace the patient-reported-data revolution
Due to present necessity and better accuracy, HCPs are finally embracing the patient-reported-data revolution.
NPs, PAs are calling on marketers to adjust educational, promotional pitches
Amid the pandemic, nurse practitioners and physician assistants have seen their practice authority surge. They’d like marketers to adjust their educational and promotional pitches accordingly.
Numerous groups are attempting to diversify COVID vaccine research
With communities of color historically underrepresented in clinical trials, numerous groups are working to diversify COVID-19 vaccine research.
